Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Sarcoma × ontuxizumab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Solid Tumor 2 Waldenstrom Macroglobulinemia 1 Sezary Syndrome 1 Sarcoma 1 Recurrence 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Neoplasm Metastasis 1 Mycosis Fungoides 1 Melanoma 1 Lymphoma, T-Cell, Peripheral 1 Lymphoma, T-Cell, Cutaneous 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Mantle-Cell 1 Lymphoma, Large-Cell, Immunoblastic 1 Lymphoma, Large-Cell, Anaplastic 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, Follicular 1 Lymphoma, Extranodal NK-T-Cell 1 Lymphoma, B-Cell, Marginal Zone 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Leukemia, Large Granular Lymphocytic 1 Leukemia, Hairy Cell 1 Intraocular Lymphoma 1 Immunoblastic Lymphadenopathy 1 Hodgkin Disease 1 Dendritic Cell Sarcoma, Interdigitating 1 Colorectal Neoplasms 1 Burkitt Lymphoma 1

Interventions

Doxorubicin 30 pembrolizumab 12 Gemcitabine 11 Irinotecan 9 pazopanib 8 eribulin 8 Trabectedin 8 olaratumab 7 Cyclophosphamide 6 anlotinib 5 Injections 5 Docetaxel 5 ridaforolimus 4 Temozolomide 4 Nivolumab 4 Ifosfamide 4 Fluorouracil 4 Carboplatin 4 Bevacizumab 4 tazemetostat 3 belinostat 3 TH 302 3 Paclitaxel 3 Ipilimumab 3 Epirubicin 3 Drug Therapy 3 Dacarbazine 3 DOXO-EMCH 3 trastuzumab deruxtecan 2 toripalimab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01574716 2019-08-21

SOURCE

Morphotek

Phase 2 Completed

209 enrolled 18 charts

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡